[What to do in neuroleptic-induced sialorrhea].
Fischer
R B
RB
D000286:Administration, Sublingual; D014150:Antipsychotic Agents / Q000009:adverse effects*; D001285:Atropine / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D006801:Humans; D008297:Male; D008875:Middle Aged; D018727:Muscarinic Antagonists / Q000008:administration & dosage / Q000627:therapeutic use*; D009883:Ophthalmic Solutions; D011618:Psychotic Disorders / Q000188:drug therapy; D012798:Sialorrhea / Q000139:chemically induced / Q000188:drug therapy*; D016896:Treatment Outcome
D014150:Antipsychotic Agents; D018727:Muscarinic Antagonists; D009883:Ophthalmic Solutions; D001285:Atropine
Was tun bei neuroleptikainduzierter Hypersalivation?